arrow
K

Kavita Y. Sarin

stanford university school of medicine
H指数:39
被引数:7,173

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis

罕见病临床试验的新方法:神经纤维瘤病1型和施万瘤的分散式试验设计

Cancers
IF4.4
2026-08-010
OA
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D

神经纤维瘤病1型中与皮肤神经纤维瘤相关的污名化:cNF-PUSH-D的发展、验证及严重程度分层

2026-02-011
PRE
A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhD

致编辑信件回复:优化风险与重新定义分期:BAP1-Mutant Mesothelioma 的隐藏含义 Shiuan-Chih Chen, MD, PhD;Yuan-Ti Lee, MD, PhD

2025-12-030
PRE
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: development and validation of the Nef-ASI.

神经纤维瘤病1型相关皮肤神经纤维瘤严重程度的测量:Nef-ASI的开发与验证。

2025-10-060
PRE
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trial

P2X7-NLRP3炎症小体抑制剂AZD9056对痤疮 inversa 临床疾病活动性无显著影响,但可恢复外周血单核细胞的细胞因子产生:一项2期试验的结果

2025-09-270
PRE
Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations

携带种系BAP1突变个体的间皮瘤的临床与病理表型分析

2025-06-270
OAAI
TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis

含RNA的免疫复合物在免疫细胞和肌肉中的TLR7/8激活: 在炎症和肌炎发病机理中的作用

2024-11-040
OAAI
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis
2024-09-170
PRE
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling
2024-07-111
OAAI